Correction to: Dipicolinic acid derivatives as inhibitors of new delhi metallo-β-lactamase-1 (Journal of Medicinal Chemistry (2017) 60 (7267-72830 DOI: 10.1021/acs.jmedchem.7b00407);Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1

Journal of Medicinal Chemistry

Volumn 60, Issue 17, 2017, Pages 7267-7283

  Chen, Allie Y ^a   Thomas, Pei W ^b   Stewart, Alesha C ^b   Bergstrom, Alexander ^c   Cheng, Zishuo ^c   Miller, Callie ^c   Bethel, Christopher R ^d   Marshall, Steven H ^d   Credille, Cy V ^a   Riley, Christopher L ^b   Page, Richard C ^c   Bonomo, Robert A ^d,e,f   Crowder, Michael W ^c   Tierney, David L ^c   Fast, Walter ^b   Cohen, Seth M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c MIAMI UNIVERSITY   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^e Department of Biochemistry ^*  (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 AMINOPHENYL)PYRIDINE 2,6 DICARBOXYLIC ACID; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; DIPICOLINIC ACID DERIVATIVE; IMIPENEM; METAL CHELATE; NEW DELHI METALLO BETA LACTAMASE 1; NEW DELHI METALLO BETA LACTAMASE 1 INHIBITOR; TRYPTOPHAN; UNCLASSIFIED DRUG; ZINC; ANTIINFECTIVE AGENT; BETA-LACTAMASE NDM-1; DIPICOLINIC ACID; PICOLINIC ACID DERIVATIVE;

ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DESIGN; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; ELECTRON SPIN RESONANCE; ENZYME ACTIVE SITE; ENZYME INHIBITION; EQUILIBRIUM DIALYSIS; ESCHERICHIA COLI; FLUORESCENCE; IC50; KLEBSIELLA PNEUMONIAE; MAMMAL CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; ULTRAVIOLET SPECTROSCOPY; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI INFECTIONS; HUMAN; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASE INHIBITORS; BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PICOLINIC ACIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 85029542504     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.8b01057     Document Type: Erratum

References (64)

1. Brown, D. G.; Wright, G. D. Antibacterial drug discovery in the resistance era Nature 2016, 529, 336-343 10.1038/nature17042
2. Bush, K.; Jacoby, G. A. Updated functional classification of beta-lactamases Antimicrob. Agents Chemother. 2010, 54, 969-976 10.1128/AAC.01009-09
3. Drawz, S. M.; Bonomo, R. A. Three decades of beta-lactamase inhibitors Clin. Microbiol. Rev. 2010, 23, 160-201 10.1128/CMR.00037-09
4. Crowder, M. W.; Spencer, J.; Vila, A. J. Metallo-beta-lactamases: novel weaponry for antibiotic resistance in bacteria Acc. Chem. Res. 2006, 39, 721-728 10.1021/ar0400241
5. Walsh, T. R. Emerging carbapenemases: a global perspective Int. J. Antimicrob. Agents 2010, 36, 8-14 10.1016/S0924-8579(10)70004-2
6. Yong, D.; Toleman, M. A.; Giske, C. G.; Cho, H. S.; Sundman, K.; Lee, K.; Walsh, T. R. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India Antimicrob. Agents Chemother. 2009, 53, 5046-5054 10.1128/AAC.00774-09
7. Nordmann, P.; Poirel, L.; Toleman, M. A.; Walsh, T. R. Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J. Antimicrob. Chemother. 2011, 66, 689-692 10.1093/jac/dkq520
8. Kumarasamy, K. K.; Toleman, M. A.; Walsh, T. R.; Bagaria, J.; Butt, F.; Balakrishnan, R.; Chaudhary, U.; Doumith, M.; Giske, C. G.; Irfan, S.; Krishnan, P.; Kumar, A. V.; Maharjan, S.; Mushtaq, S.; Noorie, T.; Paterson, D. L.; Pearson, A.; Perry, C.; Pike, R.; Rao, B.; Ray, U.; Sarma, J. B.; Sharma, M.; Sheridan, E.; Thirunarayan, M. A.; Turton, J.; Upadhyay, S.; Warner, M.; Welfare, W.; Livermore, D. M.; Woodford, N. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Lancet Infect. Dis. 2010, 10, 597-602 10.1016/S1473-3099(10)70143-2
9. Mojica, M. F.; Bonomo, R. A.; Fast, W. B1-metallo-beta-lactamases: where do we stand? Curr. Drug Targets 2016, 17, 1029-1050 10.2174/1389450116666151001105622
10. Aoki, N.; Ishii, Y.; Tateda, K.; Saga, T.; Kimura, S.; Kikuchi, Y.; Kobayashi, T.; Tanabe, Y.; Tsukada, H.; Gejyo, F.; Yamaguchi, K. Efficacy of calcium-EDTA as an inhibitor for metallo-beta-lactamase in a mouse model of Pseudomonas aeruginosa pneumonia Antimicrob. Agents Chemother. 2010, 54, 4582-4588 10.1128/AAC.00511-10
11. Yoshizumi, A.; Ishii, Y.; Livermore, D. M.; Woodford, N.; Kimura, S.; Saga, T.; Harada, S.; Yamaguchi, K.; Tateda, K. Efficacies of calcium-EDTA in combination with imipenem in a murine model of sepsis caused by Escherichia coli with NDM-1 beta-lactamase J. Infect. Chemother. 2013, 19, 992-995 10.1007/s10156-012-0528-y
12. King, A. M.; Reid-Yu, S. A.; Wang, W.; King, D. T.; De Pascale, G.; Strynadka, N. C.; Walsh, T. R.; Coombes, B. K.; Wright, G. D. Aspergillomarasmine A overcomes metallo-beta-lactamase antibiotic resistance Nature 2014, 510, 503-506 10.1038/nature13445
13. King, D. T.; Worrall, L. J.; Gruninger, R.; Strynadka, N. C. New Delhi metallo-beta-lactamase: structural insights into beta-lactam recognition and inhibition J. Am. Chem. Soc. 2012, 134, 11362-11365 10.1021/ja303579d
14. Guo, Y.; Wang, J.; Niu, G.; Shui, W.; Sun, Y.; Zhou, H.; Zhang, Y.; Yang, C.; Lou, Z.; Rao, Z. A structural view of the antibiotic degradation enzyme NDM-1 from a superbug Protein Cell 2011, 2, 384-394 10.1007/s13238-011-1055-9
15. Li, N.; Xu, Y.; Xia, Q.; Bai, C.; Wang, T.; Wang, L.; He, D.; Xie, N.; Li, L.; Wang, J.; Zhou, H. G.; Xu, F.; Yang, C.; Zhang, Q.; Yin, Z.; Guo, Y.; Chen, Y. Simplified captopril analogues as NDM-1 inhibitors Bioorg. Med. Chem. Lett. 2014, 24, 386-389 10.1016/j.bmcl.2013.10.068
16. Klingler, F. M.; Wichelhaus, T. A.; Frank, D.; Cuesta-Bernal, J.; El-Delik, J.; Muller, H. F.; Sjuts, H.; Gottig, S.; Koenigs, A.; Pos, K. M.; Pogoryelov, D.; Proschak, E. Approved drugs containing thiols as inhibitors of metallo-beta-lactamases: strategy to combat multidrug-resistant bacteria J. Med. Chem. 2015, 58, 3626-3630 10.1021/jm501844d
17. Garcia-Saez, I.; Hopkins, J.; Papamicael, C.; Franceschini, N.; Amicosante, G.; Rossolini, G. M.; Galleni, M.; Frere, J. M.; Dideberg, O. The 1.5-Å structure of Chryseobacterium meningosepticum zinc beta-lactamase in complex with the inhibitor, D-captopril J. Biol. Chem. 2003, 278, 23868-23873 10.1074/jbc.M301062200
18. Jaffe, I. A. Adverse effects profile of sulfhydryl compounds in man Am. J. Med. 1986, 80, 471-476 10.1016/0002-9343(86)90722-9
19. Kitamura, K.; Aihara, M.; Osawa, J.; Naito, S.; Ikezawa, Z. Sulfhydryl drug-induced eruption: a clinical and histological study J. Dermatol. 1990, 17, 44-51 10.1111/j.1346-8138.1990.tb01608.x
20. Brem, J.; Cain, R.; Cahill, S.; McDonough, M. A.; Clifton, I. J.; Jimenez-Castellanos, J. C.; Avison, M. B.; Spencer, J.; Fishwick, C. W.; Schofield, C. J. Structural basis of metallo-beta-lactamase, serine-beta-lactamase and penicillin-binding protein inhibition by cyclic boronates Nat. Commun. 2016, 7, 12406 10.1038/ncomms12406
21. Fast, W.; Sutton, L. D. Metallo-beta-lactamase: inhibitors and reporter substrates Biochim. Biophys. Acta, Proteins Proteomics 2013, 1834, 1648-1659 10.1016/j.bbapap.2013.04.024
22. Gonzalez, M. M.; Kosmopoulou, M.; Mojica, M. F.; Castillo, V.; Hinchliffe, P.; Pettinati, I.; Brem, J.; Schofield, C. J.; Mahler, G.; Bonomo, R. A.; Llarrull, L. I.; Spencer, J.; Vila, A. J. Bisthiazolidines: a substrate-mimicking scaffold as an inhibitor of the NDM-1 carbapenemase ACS Infect. Dis. 2015, 1, 544-554 10.1021/acsinfecdis.5b00046
23. Hinchliffe, P.; Gonzalez, M. M.; Mojica, M. F.; Gonzalez, J. M.; Castillo, V.; Saiz, C.; Kosmopoulou, M.; Tooke, C. L.; Llarrull, L. I.; Mahler, G.; Bonomo, R. A.; Vila, A. J.; Spencer, J. Cross-class metallo-beta-lactamase inhibition by bisthiazolidines reveals multiple binding modes Proc. Natl. Acad. Sci. U. S. A. 2016, 113, 3745-3754 10.1073/pnas.1601368113
24. Zartler, E.; Shapiro, M. Designing a Fragment Process To Fit Your Needs. In Fragment-Based Drug Discovery: A Practical Approach; John Wiley & Sons: Chichester, U.K., 2008; DOI: 10.1002/9780470721551.ch2.
25. Garau, G.; Garcia-Saez, I.; Bebrone, C.; Anne, C.; Mercuri, P.; Galleni, M.; Frere, J. M.; Dideberg, O. Update of the standard numbering scheme for class B beta-lactamases Antimicrob. Agents Chemother. 2004, 48, 2347-2349 10.1128/AAC.48.7.2347-2349.2004
26. Agrawal, A.; de Oliveira, C. A.; Cheng, Y.; Jacobsen, J. A.; McCammon, J. A.; Cohen, S. M. Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor J. Med. Chem. 2009, 52, 1063-1074 10.1021/jm8013212
27. Agrawal, A.; Johnson, S. L.; Jacobsen, J. A.; Miller, M. T.; Chen, L. H.; Pellecchia, M.; Cohen, S. M. Chelator fragment libraries for targeting metalloproteinases ChemMedChem 2010, 5, 195-199 10.1002/cmdc.200900516
28. Lewis, J. A.; Mongan, J.; McCammon, J. A.; Cohen, S. M. Evaluation and binding-mode prediction of thiopyrone-based inhibitors of anthrax lethal factor ChemMedChem 2006, 1, 694-697 10.1002/cmdc.200600102
29. Puerta, D. T.; Schames, J. R.; Henchman, R. H.; McCammon, J. A.; Cohen, S. M. From model complexes to metalloprotein inhibition: a synergistic approach to structure-based drug discovery Angew. Chem., Int. Ed. 2003, 42, 3772-3774 10.1002/anie.200351433
30. Puerta, D. T.; Mongan, J.; Tran, B. L.; McCammon, J. A.; Cohen, S. M. Potent, selective pyrone-based inhibitors of stromelysin-1 J. Am. Chem. Soc. 2005, 127, 14148-14149 10.1021/ja054558o
31. Rouffet, M.; de Oliveira, C. A.; Udi, Y.; Agrawal, A.; Sagi, I.; McCammon, J. A.; Cohen, S. M. From sensors to silencers: quinoline- and benzimidazole-sulfonamides as inhibitors for zinc proteases J. Am. Chem. Soc. 2010, 132, 8232-8233 10.1021/ja101088j
32. Copeland, R. A. Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists Methods Biochem. Anal. 2005, 46, 1-265
33. Zhang, J. H.; Chung, T. D.; Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays J. Biomol. Screening 1999, 4, 67-73 10.1177/108705719900400206
34. Schlesinger, S. R.; Bruner, B.; Farmer, P. J.; Kim, S. K. Kinetic characterization of a slow-binding inhibitor of Bla2: thiomaltol J. Enzyme Inhib. Med. Chem. 2013, 28, 137-142 10.3109/14756366.2011.640632
35. Hanaya, K.; Suetsugu, M.; Saijo, S.; Yamato, I.; Aoki, S. Potent inhibition of dinuclear zinc(II) peptidase, an aminopeptidase from Aeromonas proteolytica, by 8-quinolinol derivatives: inhibitor design based on Zn2+ fluorophores, kinetic, and X-ray crystallographic study JBIC, J. Biol. Inorg. Chem. 2012, 17, 517-529 10.1007/s00775-012-0873-4
36. Horsfall, L. E.; Garau, G.; Lienard, B. M.; Dideberg, O.; Schofield, C. J.; Frere, J. M.; Galleni, M. Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila Antimicrob. Agents Chemother. 2007, 51, 2136-2142 10.1128/AAC.00866-06
37. Aitha, M.; Moller, A. J.; Sahu, I. D.; Horitani, M.; Tierney, D. L.; Crowder, M. W. Investigating the position of the hairpin loop in New Delhi metallo-beta-lactamase, NDM-1, during catalysis and inhibitor binding J. Inorg. Biochem. 2016, 156, 35-39 10.1016/j.jinorgbio.2015.10.011
38. Okabe, N.; Oya, N. Copper(II) and zinc(II) complexes of pyridine-2,6-dicarboxylic acid Acta Crystallogr., Sect. C: Cryst. Struct. Commun. 2000, 56 (3) 305-307 10.1107/S0108270199015565
39. Rukavishnikov, A.; Gee, K. R.; Johnson, I.; Corry, S. Fluorogenic cephalosporin substrates for beta-lactamase TEM-1 Anal. Biochem. 2011, 419, 9-16 10.1016/j.ab.2011.07.020
40. Hopkins, A. L.; Groom, C. R.; Alex, A. Ligand efficiency: a useful metric for lead selection Drug Discovery Today 2004, 9, 430-431 10.1016/S1359-6446(04)03069-7
41. Brown, D. G.; May-Dracka, T. L.; Gagnon, M. M.; Tommasi, R. Trends and exceptions of physical properties on antibacterial activity for Gram-positive and Gram-negative pathogens J. Med. Chem. 2014, 57, 10144-10161 10.1021/jm501552x
42. Gregoretti, I. V.; Lee, Y. M.; Goodson, H. V. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis J. Mol. Biol. 2004, 338, 17-31 10.1016/j.jmb.2004.02.006
43. Devel, L.; Rogakos, V.; David, A.; Makaritis, A.; Beau, F.; Cuniasse, P.; Yiotakis, A.; Dive, V. Development of selective inhibitors and substrate of matrix metalloproteinase-12 J. Biol. Chem. 2006, 281, 11152-11160 10.1074/jbc.M600222200
44. Sly, W. S.; Hu, P. Y. Human carbonic anhydrases and carbonic anhydrase deficiencies Annu. Rev. Biochem. 1995, 64, 375-401 10.1146/annurev.bi.64.070195.002111
45. Day, J. A.; Cohen, S. M. Investigating the selectivity of metalloenzyme inhibitors J. Med. Chem. 2013, 56, 7997-8007 10.1021/jm401053m
46. Chen, Y.; Cohen, S. M. Investigating the selectivity of metalloenzyme inhibitors in the presence of competing metalloproteins ChemMedChem 2015, 10, 1733-1738 10.1002/cmdc.201500293
47. Yang, H.; Aitha, M.; Hetrick, A. M.; Richmond, T. K.; Tierney, D. L.; Crowder, M. W. Mechanistic and spectroscopic studies of metallo-beta-lactamase NDM-1 Biochemistry 2012, 51, 3839-3847 10.1021/bi300056y
48. Yang, H.; Aitha, M.; Marts, A. R.; Hetrick, A.; Bennett, B.; Crowder, M. W.; Tierney, D. L. Spectroscopic and mechanistic studies of heterodimetallic forms of metallo-beta-lactamase NDM-1 J. Am. Chem. Soc. 2014, 136, 7273-7285 10.1021/ja410376s
49. Selleck, C.; Larrabee, J. A.; Harmer, J.; Guddat, L. W.; Mitić, N.; Helweh, W.; Ollis, D. L.; Craig, W. R.; Tierney, D. L.; Monteiro Pedroso, M.; Schenk, G. AIM-1: an antibiotic-degrading metallohydrolase that displays mechanistic flexibility Chem.-Eur. J. 2016, 22, 17704-17714 10.1002/chem.201602762
50. Bennett, B. In Metals in Biology: Applications of High-Resolution EPR to Metalloenzymes; Hanson, G.; Berliner, L., Eds.; Springer New York: New York, NY, 2010; pp 345-370.
51. Crowder, M. W.; Yang, K. W.; Carenbauer, A. L.; Periyannan, G.; Seifert, M. E.; Rude, N. E.; Walsh, T. R. The problem of a solvent exposable disulfide when preparing Co(II)-substituted metallo-beta-lactamase L1 from Stenotrophomonas maltophilia JBIC, J. Biol. Inorg. Chem. 2001, 6, 91-99 10.1007/s007750000173
52. Krezel, A.; Maret, W. The biological inorganic chemistry of zinc ions Arch. Biochem. Biophys. 2016, 611, 3-19 10.1016/j.abb.2016.04.010
53. Lascols, C.; Hackel, M.; Marshall, S. H.; Hujer, A. M.; Bouchillon, S.; Badal, R.; Hoban, D.; Bonomo, R. A. Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009) J. Antimicrob. Chemother. 2011, 66, 1992-1997 10.1093/jac/dkr240
54. Christopeit, T.; Carlsen, T. J.; Helland, R.; Leiros, H. K. Discovery of novel inhibitor scaffolds against the metallo-β-lactamase VIM-2 by surface plasmon resonance (SPR) based fragment screening J. Med. Chem. 2015, 58, 8671-8682 10.1021/acs.jmedchem.5b01289
55. Christopeit, T.; Leiros, H. K. Fragment-based discovery of inhibitor scaffolds targeting the metallo-β-lactamases NDM-1 and VIM-2 Bioorg. Med. Chem. Lett. 2016, 26, 1973-1977 10.1016/j.bmcl.2016.03.004
56. Klingler, F. M.; Moser, D.; Buttner, D.; Wichelhaus, T. A.; Lohr, F.; Dotsch, V.; Proschak, E. Probing metallo-beta-lactamases with molecular fragments identified by consensus docking Bioorg. Med. Chem. Lett. 2015, 25, 5243-5246 10.1016/j.bmcl.2015.09.056
57. Yu, S.; Vosbeek, A.; Corbella, K.; Severson, J.; Schesser, J.; Sutton, L. D. A chromogenic cephalosporin for beta-lactamase inhibitor screening assays Anal. Biochem. 2012, 428, 96-98 10.1016/j.ab.2012.06.006
58. Perez, C.; Monserrat, J. P.; Chen, Y.; Cohen, S. M. Exploring hydrogen peroxide responsive thiazolidinone-based prodrugs Chem. Commun. 2015, 51, 7116-7119 10.1039/C4CC09921D
59. Griffin, D. H.; Richmond, T. K.; Sanchez, C.; Moller, A. J.; Breece, R. M.; Tierney, D. L.; Bennett, B.; Crowder, M. W. Structural and kinetic studies on metallo-beta-lactamase IMP-1 Biochemistry 2011, 50, 9125-9134 10.1021/bi200839h
60. Aitha, M.; Marts, A. R.; Bergstrom, A.; Moller, A. J.; Moritz, L.; Turner, L.; Nix, J. C.; Bonomo, R. A.; Page, R. C.; Tierney, D. L.; Crowder, M. W. Biochemical, mechanistic, and spectroscopic characterization of metallo-beta-lactamase VIM-2 Biochemistry 2014, 53, 7321-7331 10.1021/bi500916y
61. Martin, D. P.; Cohen, S. M. Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors Chem. Commun. 2012, 48, 5259-5261 10.1039/c2cc32013d
62. Monnard, F. W.; Heinisch, T.; Nogueira, E. S.; Schirmer, T.; Ward, T. R. Human carbonic anhydrase II as a host for piano-stool complexes bearing a sulfonamide anchor Chem. Commun. 2011, 47, 8238-8240 10.1039/c1cc10345h
63. Riley, E. A.; Petros, A. K.; Smith, K. A.; Gibney, B. R.; Tierney, D. L. Frequency-switching inversion-recovery for severely hyperfine-shifted NMR: evidence of asymmetric electron relaxation in high-spin Co(II) Inorg. Chem. 2006, 45, 10016-10018 10.1021/ic061207h
64. CLSI M07-A10, 2 ed.; Clinical and Laboratory Standards Institute: Wayne, PA, U.S., 2015; Vol. 35.